Just a few weeks after President Donald Trump’s December promise that prescription drug prices would plummet “fast and furious,” Patricia Brown checked into a California clinic for an infusion of Merck & Co.’s blockbuster cancer drug, Keytruda. When the bill arrived, the clinic’s charge for a 400 mg dose dominated the page: $162,567.74. Brown, an accomplished cook battling lung cancer…
















